The synthetic opioid cychlorphine has been linked to at least 55 deaths nationally from 2025 to 2026, with prevalence highest in Ohio, Tennessee and Texas, MedPage Today reported Sept. 8. The Office of National Drug Control Policy said in an…
Clinical Leadership & Infection Control
The cost of getting high on opioids has fallen more than 90% over the last two decades as illicit drugs have become more potent and overdose deaths have risen, according to an Aug. 24 New York Times report. Here are…
After implementing a new diagnostic code, the CDC found monthly proportions of emergency department visits for cannabis hyperemesis syndrome was 3.7 times higher between October 2025 and May 2026 compared to visits between January 2023 and September 2025. Cannabis hyperemesis…
Arizona has overtaken West Virginia as the state with the highest drug death rate in the contiguous U.S., marking the first time since the prescription opioid epidemic began that West Virginia has lost the distinction. The shift has been fueled…
A toxicology journal has retracted a 2010 study that claimed male newborns vaccinated against hepatitis B in their first month of life had threefold greater odds of an autism diagnosis than those vaccinated later or not at all. In a…
Advertisement
U.S. drug overdose deaths are falling at a pace not seen in a generation — and the latest federal data suggests the decline is broad and accelerating. Provisional drug overdose deaths dropped in 42 of 50 states in the 12…
California’s workplace safety regulator has cited Zuckerberg San Francisco General Hospital and the University of California San Francisco a combined $273,200 in proposed penalties following the fatal stabbing of a social worker at the hospital’s HIV clinic in December. The…
A new class of synthetic opioids known as orphines is emerging in the U.S., raising concerns for public health officials and clinicians, The New York Times reported May 5. Orphines began appearing in the U.S. drug supply in the fall,…
Oxford Treatment Center in Etta, Miss., reported a 35% increase in patients identifying alcohol as their primary substance of concern over the past year. The trend reflects a broader public health issue, as alcohol use disorder affects approximately 1 in…
The federal government launched a behavioral health research initiative, with $50 million allocated to match state investments in psychedelic research, including psilocybin, a hallucinogenic compound being studied to treat serious mental illness. Research interest in psilocybin is growing, particularly for…